The aim of this study was immunohistochemical evaluation of heat shock protein (Hsp70) and p-53 proteins in the Larginine- induced cellular stress in hepatocytes of rats. Sixteen white Wistar female rats were divided into two equal groups. The rats from the experimental group received per os 40 mg/kg b.w. of L-arginine every day for 2 weeks and were decapitated after 3 weeks of the experiment. The rats from the control group received in the same manner 2 ml of distilled water and were decapitated after 3 weeks of the experiment. After decapitation specimens from the liver were collected, fixed in 10% formalin, and then embedded in paraffin blocks. Proteins Hsp70 and p-53 were detected on slides using the standard three step immunohistochemical method. The quantitative evaluation of Hsp70 and p-53 expression showed that the area of positive staining in the liver of the experimental rats (Hsp70 305,763.00 μm² +/-58,289.66, p-53 9,551.42 μm² +/-1,078.86) was comparable to that in the control groups (Hsp70 291,636.80 μm² +/-34,492.31, p-53 14,104.67 μm² +/-3,571.35). Our experiment showed, that L-arginine as a precursor of exogenous nitric oxide given to rats in dose similar to that used in pregnant women treated for hypertension did not exhibit an influence on hepatocytes.
1. Appleton J.: Arginine: clinical potential of a semiessential amino. Altern Med Rev 2002, 7, 512-522.
2. Augustyniak A., Michalak K., Skrzydlewska E.: The action of oxidative stress induced by ethanol on the central nervous system (CNS). Postepy Hig Med Dosw 2005, 59, 464-471.
3. Chae I.H., Park K.W., Kim H.S., Oh B.H.: Nitric oxideinduced apoptosis is mediated by BAX/Bcl-2 gene expression, transition of cytochrome C, and activation of caspase-3 in rat vascular smooth muscle cells. Clin Chim Acta 2004, 341, 83-91.
4. Cherla G., Jaimes E.A.: Role of L-arginine in the pathogenesis and treatment of renal disease. J Nutr 2004, 134, 2801S-2806S.
5. Dash P.R., Cartwiright J.E., Baker P.N., Johnstone A.P., Whitley G.S.: Nitric oxide protects human extravillous trophoblast cells from apoptosis by a cylic GMPdependent mechanism and independently of caspase 3 nitrosilation. Exp Cell Res 2003, 287, 314-324.
6. Eu J.P., Liu L., Zeng M., Stamler J.S.: An apoptotic model for nitrosative stress. Biochemistry 2000, 39, 1040-1047.
7. Farzaneh P., Allameh A., Pratt S., Moore N., Travis l., Gottschalg E., Kind C., Fry J.: Increased heat shock protein 70 expression following toxicant-mediated cytotoxicity: a ubiquitous marker of toxicant exposure? Altern Lab Anim. 2005, 33, 105-110.
8. Gryglewski R.J.: Interactions between nitric oxide and prostacyclin. Semin Thromb Hemostas 1993, 19, 158-164.
9. Huguenin S., Fleury-Feith J., Kheuang L., Jourand M.C., Bolla M., Riffaud J.P., Chopin D.K., Vacherot F.: Nitrosulindac (NCX 1102): a new nitric oxide-donating non-steroidal anti-inflammatory drug (NO-NSAID),inhibits proliferation and induces apoptosis in human prostatic epithelial cell lines. Prostate 2004, 61, 132-141.
10. Kastan M.B., Onyckwere O., Sidransky D., Vogelstein B., Craig R.W.: Participation of p-53 protein in the cellular response to DNA damage. Cancer Res 1991, 51, 6304-6311.
11. Kronon M.T., Allen B.S., Halldorsson A., Rahman S., Wang T., Ilbawi M.: Dose dependency of L-arginine in neonatal myocardial protection: the nitric oxide paradox. Thorac Cardiovasc Surg 1999, 118, 655-664.
12. Mukhopadhyay I., Nazir A., Saxena D.K., Chowdhuri D.K.: Toxicity of cypermethrin: HSp70 as a biomarker of response in transgenic Drosophila. Biomarkers 2002, 7, 501-510.
13. Pedrycz A., Kot K., Olesiński I.: Immunohistochemical evaluation of caspase 3 expression in rats' hepatocytes after L-arginine therapy. Bull Vet Inst Pulawy 2010, 54, 101-103.
14. Rolye J.S., Ross J.A., Ansell I., Bollina P., Tulloch D.N., Habib F.K.: Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspase-3. J Urol 2004, 172, 338-344.
15. Rytlewski K., Olszanecki R., Korbut R., Zdebski Z.: Effects of prolonged oral supplementation with larginine on blood pressure and nitric oxide synthesis in preeclampsia: Eur J Clin Invest 2005, 35, 32-37.
16. Rytlewski K., Zdebski Z.: Nitric oxide - one of the mechanisms that prevent changes that occur during pregnancy. Gin Pol 2001, 72, 738-743.
17. Soti C., Nagy E., Giricz Z., Vigh l., Csermely P., Ferdinandy P.: Heat shock proteins as emerging therapeutic targets. Br J Pharmacol 2005, 146, 769-780.
18. Steele R.J.C., Thompson A.M., Hall A.P., Lane D.P.: The p53 tumor suppressor gene. Br J Surg 1998, 85, 1460-1467.
19. Yoo J.L., Janz D.M.: Tissue-specific HSP70 levels and reproductive physiological responses in fishes inhabiting a metal-contaminated creek. Arch Environ Contam Toxicol 2003, 45, 110-120.